Celltrion
068270.KS
#732
Rank
A$44.08 B
Marketcap
$202.00
Share price
0.65%
Change (1 day)
-0.65%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.50

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.73. In 2022 the company made an earnings per share (EPS) of $4.60 a decrease over its 2021 EPS that were of $5.47.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.50-2.26%
2022$4.60-15.84%
2021$5.4712.77%
2020$4.8570.79%
2019$2.8415.63%
2018$2.45-33.13%
2017$3.67141.17%
2016$1.528.28%
2015$1.4111.28%
2014$1.2616.37%
2013$1.09-67.42%
2012$3.3384.22%
2011$1.8162.13%
2010$1.1280.61%
2009$0.62-559.63%
2008-$0.13-123.16%
2007$0.58